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ABSTRACT
The alphaviral 6k gene region encodes the two structural proteins 6K protein and, due to a ribosomal frameshift event, the trans-
frame protein (TF). Here, we characterized the role of the 6k proteins in the arthritogenic alphavirus Ross River virus (RRV) in
infected cells and in mice, using a novel 6k in-frame deletion mutant. Comprehensive microscopic analysis revealed that the 6k
proteins were predominantly localized at the endoplasmic reticulum of RRV-infected cells. RRV virions that lack the 6k proteins
6K and TF [RRV-(6K)] were more vulnerable to changes in pH, and the corresponding virus had increased sensitivity to a
higher temperature. While the 6k deletion did not reduce RRV particle production in BHK-21 cells, it affected virion release
from the host cell. Subsequent in vivo studies demonstrated that RRV-(6K) caused a milder disease than wild-type virus, with
viral titers being reduced in infected mice. Immunization of mice with RRV-(6K) resulted in a reduced viral load and acceler-
ated viral elimination upon secondary infection with wild-type RRV or another alphavirus, chikungunya virus (CHIKV). Our
results show that the 6k proteins may contribute to alphaviral disease manifestations and suggest that manipulation of the 6k
gene may be a potential strategy to facilitate viral vaccine development.
IMPORTANCE
Arthritogenic alphaviruses, such as chikungunya virus (CHIKV) and Ross River virus (RRV), cause epidemics of debilitating
rheumatic disease in areas where they are endemic and can emerge in new regions worldwide. RRV is of considerable medical
significance in Australia, where it is the leading cause of arboviral disease. The mechanisms by which alphaviruses persist and
cause disease in the host are ill defined. This paper describes the phenotypic properties of an RRV 6k deletion mutant. The ab-
sence of the 6k gene reduced virion release from infected cells and also reduced the severity of disease and viral titers in infected
mice. Immunization with the mutant virus protected mice against viremia not only upon exposure to RRV but also upon chal-
lenge with CHIKV. These findings could lead to the development of safer andmore immunogenic alphavirus vectors for vaccine
delivery.
Alphaviruses like Ross River virus (RRV), Barmah Forest virus(BFV), Semliki Forest virus (SFV), Sindbis virus (SINV), chi-
kungunya virus (CHIKV), and O’nyong-nyong virus (ONNV) are
small, enveloped RNA viruses of the family Togaviridae. They fre-
quently cause human diseases manifesting with signs and symp-
toms such as encephalitis, acute or persistent arthritis, fever, ar-
thralgia, and myalgia (1). RRV is a prevalent disease-causing
alphavirus in the Australasian region and a major health hazard,
with 5,000 cases of Ross River virus disease (RRVD) reported an-
nually (2). Patients infected with RRV can develop a febrile illness,
rash, polyarthritis, and myalgia (3). A number of patients also
experience chronic arthralgia and debilitating joint pain that can
last for months. Despite this, the pathogenic determinants of RRV
have not been extensively studied.
The alphaviral genome comprises the 5= region, encoding the
nonstructural proteins, and the 3= region, encoding the structural
proteins. The structural proteins, capsid protein (C), glycopro-
teins E1, E2, and E3, 6K protein, and transframe protein (TF), are
derived from progressive cleavage of the major polyproteins,
C-E3-E2-6K-E1, and minor polyproteins, C-E3-E2-TF (1). TF
shares the same N-terminal sequence as the 6K protein but con-
tains an extended C terminus as a result of ribosomal frameshift-
ing that occurs during the translation of the 6k gene (2). C, E2, and
E1 are the obligatory components of mature virions that morpho-
logically appear as a nucleocapsid enveloped by a lipid bilayer that
is studded with E1/E2 trimers.
Although the 6K and TF 6k proteins are translated alongside
the other structural proteins, they are generally present at very low
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levels within virus particles (4–6). Both 6k proteins are mem-
brane-associated proteins, containing hydrophobic (supposed
transmembrane) domains and numerous acylated amino acid res-
idues (4, 7). The role of the 6k proteins in alphaviral disease re-
mains unclear, although they have been shown to be involved in
processes of viral replication, assembly, and release. For example,
mutations of SINV 6k resulting from either an in-frame insertion
of 15 amino acids in the 6k gene (8) or a deletion of 21 amino acids
from the 6k gene (9) led to defective glycoprotein processing, traf-
ficking, and viral budding. These findings are in line with a previ-
ous report demonstrating the involvement of an SFV 6k protein
sequence in the insertion of E1 into the endoplasmic reticulum
(ER) membrane (10). Interestingly, complete deletion of the SFV
6k gene had little effect on glycoprotein processing and transport
but significantly impaired the release of virus particles, suggesting
a role for the 6k proteins in viral assembly or budding (5, 11).
Similarly, disruption of SINV TF production reduced infectious
particle release during infection (6). The severity of disease expe-
rienced by mice infected with SINV TF mutants was also greatly
reduced relative to the severity of disease experienced by mice
infected with the wild-type virus in a model of SINV neuropatho-
genesis (6). The size, hydrophobicity, and structural characteris-
tics of the alphaviral 6k proteins led to the hypothesis that they
could function as viral ion channels, or viroporins. In this model,
the 6k proteins are thought to be responsible for increasing host
cell plasma membrane permeability, a common phenomenon of
cytolytic viral infections (12–14). A number of studies also sup-
ported a role for the alphaviral 6K protein in enhancing mem-
brane permeability through alternative mechanisms (15–18).
The 6k region is not highly conserved among the alphaviruses.
In particular, the relevance of the 6k proteins for the replication
and pathogenesis of RRV has not been assessed, despite the im-
portance of this virus. Hence, we have constructed a 6K/TF dele-
tion mutant of RRV [RRV-(6K)] containing an in-frame dele-
tion of the entire 6k gene region, thereby ensuring that the
translation of proteins encoded by sequences on either side of the
6k gene region remains unaffected. Therefore, the potential cave-
ats associated with partial gene deletions or insertions, as were
done previously for SINV 6k (8, 9), are avoided. Using this mu-
tant, we demonstrate that the 6k proteins are involved in virus
release in BHK-21 cells. Furthermore, we show that RRV-(6K)
induces only mild disease in mice compared to the severity of
the disease induced by its wild-type (WT) counterpart and that
the viral load is reduced. RRV-(6K)-immunized mice pos-
sessed the capacity to significantly reduce viremia upon alpha-
virus challenge. These results demonstrate the major role of the
6kproteins in RRV pathogenesis and the potential of 6kdeletion as
a vaccination strategy against RRV.
MATERIALS AND METHODS
Cells. Baby hamster kidney (BHK-21; ATCC CCL-10) cells were main-
tained at 37°C in F15 medium supplemented with nonessential amino
acids, 5% fetal calf serum (FCS), 10% tryptose phosphate broth, and 2
mM glutamine. Vero cells (ATCC CCL-81) were cultured in Opti-MEM
medium supplemented with 10% FCS. Human osteosarcoma (HOS) cells
(ATCC CRL-1543) were maintained in Dulbecco’s modified Eagle’s me-
dium (DMEM) with 10% FCS, and HOS cells stably transfected with
enhanced green fluorescent protein (EGFP)-tagged LC3 (19) were kept in
DMEM with 10% FCS and 1 g/liter G418.
Constructionof anRRV6kdeletionmutant.The fragment of pRR64,
an RRV T48 infectious cDNA clone, spanning from the RsrII to the SmaI
restriction site was cloned into pKS (Stratagene, Germany). The se-
quence corresponding to the 6k region was removed by polymerase in-
complete primer extension PCR (20) using oligonucleotides with the se-
quences 5=-TGC TCG TAT GCG TTC GCC CTC GGT GCG CAG C-3=
and 5=-GAA CGC ATA CGA GCA CAC AGC CAC AAT TCC GAA TGT
GG-3= as the primers and Phusion DNA polymerase (Thermo Scientific,
USA) as the enzyme. The fragment containing the correct deletion was
used to replace the corresponding fragment of pRR64. The sequence of
the obtained clone, designated pRR64-(6K), was verified by sequencing.
Viruses. Infectious RRV RNA transcripts were generated as described
by Kuhn et al. (21). Briefly, pRR64 and pRR64-(6K) were linearized with
SacI and transcribed using SP6 RNA polymerase, to generate full-length
transcripts that were 5= capped by the inclusion of m7G(5=)ppp(5=)A in
the transcription reaction. BHK-21 cells were transfected with these RNAs
by electroporation, and both WT RRV and the 6k deletion mutant [RRV-
(6K)] were harvested at 24 to 48 h posttransfection. The deletion of the
6k region was confirmed by RT-PCR, and the lack of 6K protein expres-
sion was verified by immunofluorescence. CHIKV (Bali isolate) was
kindly provided by Linda Hueston (Centre for Infectious Diseases & Mi-
crobiology Laboratory Services, Westmead Hospital, Sydney, Australia)
and propagated in Vero cells.
Infection and replication in cell culture. Cells were infected with vi-
ruses in Hanks’ buffered salt solution (HBSS) at a multiplicity of infection
(MOI) of 0.1 PFU/cell. Following adsorption of virus for 1 h at 37°C, cell
monolayers were washed and fresh growth medium was added. The cul-
ture medium was assayed for the presence of infectious particles at various
time points. To determine the amount of cell-associated virus, cell mono-
layers were washed and lysed by osmotic shock and four freeze-thaw cy-
cles to release internal virus particles. The cell lysate was then assayed for
infectious particles by a plaque assay or for viral RNA by reverse transcrip-
tion-quantitative PCR (RT-qPCR).
Temperature sensitivity. Plaque assays were performed on Vero cells
incubated at 37°C, 39°C, or 41°C. Cells were incubated with WT RRV or
RRV-(6K) for 1 h, the virus inoculum was removed, and an overlay of
semisolid medium (0.16% agarose in DMEM with 2% FCS) was added to
the cells. The cells were incubated at the temperatures specified below for
48 h prior to staining with crystal violet. To assay the thermal stability of
WT RRV or RRV-(6K) particles, 100 PFU of each virus was incubated at
52°C or 56°C for 0, 6, or 12 min and cooled on ice. BHK-21 cells were
incubated with virus for 1 h at 37°C and overlaid with semisolid medium
(2% carboxymethyl cellulose [CMC] in Glasgow minimum essential me-
dium [GMEM]). At 72 h postinfection (p.i.), the cells were fixed with 10%
formaldehyde for 20 min and stained with crystal violet. The experiments
were repeated three times.
pH sensitivity assessment. WT RRV or RRV-(6K) (100 PFU) was
treated at room temperature with 0.3 M morpholinoethanesulfonic acid
(MES) at pH 5.5 for 0, 10, 20, 30, 40, 50, or 60 s and neutralized with 1 M
NaOH. BHK-21 cells were incubated with virus for 1 h at 37°C and over-
laid with semisolid medium (2% CMC in GMEM). At 72 h p.i., the cells
were fixed with 10% formaldehyde for 20 min and stained with crystal
violet. The experiments were repeated three times.
Virus quantification. (i) Infectious viral particle quantification by
plaque assay. All plaque assays on Vero cells were performed as described
previously (22).
(ii) Viral load quantification by RT-qPCR. RNA extraction was per-
formed using the TRIzol reagent (Life Technologies) following the man-
ufacturer’s instructions. Extracted RNA was reverse transcribed using
random nonamers and Moloney murine leukemia virus reverse transcrip-
tase (Sigma-Aldrich) according to the manufacturer’s instructions. A
standard curve was generated using serial dilutions of pRR64 as described
previously (23). Quantification of the viral load was performed using
SsoAdvanced universal probes supermix (Bio-Rad) in a 12.5-l reaction
volume to detect the nsP3 region (23). Primers nsp3 Forward (5=-CCG
TGG CGG GTA TTA TCA AT-3=) and nsp3 Reverse (5=-AAC ACT CCC
GTC GAC AAC AGA-3=) and fluorogenic probe RRV nsp3 (5=-ATT AAG
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AGT GTA GCC ATC C-3=) were used All reactions were performed using
a Bio-Rad CFX96 Touch real-time PCR detection system in 96-well plates.
Cycler conditions were as follows: (i) a PCR initial activation step of 95°C
for 15 min for 1 cycle and (ii) 3-step cycling at 94°C for 15 s, followed by
55°C for 30 s and 72°C for 30 s for 40 cycles. A dissociation curve was
acquired using CFX Manager software to determine the specificity of the
amplified products. A standard curve was plotted, and the copy numbers
of the amplified products were interpolated from the standard curve using
GraphPad Prism software to determine the viral load.
Immunofluorescence. Cells were grown on glass coverslips and in-
fected with virus as described above. Nonpermeabilized cells were fixed on
ice for 30 min with 2% paraformaldehyde in phosphate-buffered saline
(PBS), or, alternatively, cells were permeabilized and fixed with 2% para-
formaldehyde containing 0.1% Triton X-100 in PBS, followed by blocking
in 5% horse serum in PBS at 4°C for at least 16 h. RRV 6k proteins and E2
were labeled using rabbit polyclonal antibodies raised against the RRV 6K
N-terminal region or the RRV E2 protein; mouse monoclonal antibodies
against double-stranded RNA (monoclonal antibody J2; English and Sci-
entific Consulting), calnexin (monoclonal antibody AF18; catalog num-
ber MA3027; Pierce/Thermo), GM130 (catalog number 610822; Becton
Dickinson), EEA1 (catalog number 610456; Becton Dickinson), and
LAMP1 (catalog number ab25630; Abcam) were employed to stain repli-
cation complexes, the ER, cis-Golgi network, early endosomes, and lyso-
somes, respectively. Human cells had to be used for this analysis because
not all these organelle marker antibodies reacted with the hamster pro-
teins in BHK-21 cells (data not shown). Autophagosomes were detected
by fluorescence of EGFP-tagged LC3 in HOS cells stably transfected with
this marker (19). Antibodies were diluted in 5% horse serum-PBS; incu-
bation was performed for 2 to 5 h at 21°C, followed by washing in PBS; and
secondary antibodies were applied for 30 min at 21°C; suitable fluorescein
isothiocyanate (FITC)-, Alexa Fluor 488-, or Alexa Fluor 555-labeled anti-
rabbit and anti-mouse immunoglobulin secondary antibodies plus
DRAQ5 (Thermo) were used to stain the nuclei. Samples were imaged
with either an Olympus FV1000 confocal microscope or a Leica TCS SP5
X confocal microscope equipped with a supercontinuum pulsed white
laser.
Mouse studies. The mouse model of RRV infection was established as
described previously by Lidbury et al. (22). To assess the pathogenic po-
tentials of WT RRV and RRV-(6K), 17-day-old outbred Swiss mice were
infected intraperitoneally (i.p.) with 103 PFU of each virus and the clinical
manifestations were monitored for 20 days postinfection. Mock-inocu-
lated animals were injected with the diluent alone. Clinical scores and
body weights were recorded as previously described (24). To evaluate the
prophylactic potential of RRV-(6K), 21-day-old C57BL/6 mice were
infected with 104 PFU RRV-(6K). At day 30 postinfection, the C57BL/6
mice were challenged with 106 PFU RRV T48 or CHIKV. Viral titers in
sera were evaluated by plaque assay at days 1, 2, and 3 postchallenge. All
experiments were approved by the animal ethics committees of the Uni-
versity of Canberra and The Australian National University.
Statistical analysis. The statistical significance between experimental
groups was determined by the Student’s unpaired t test (P 0.05). Data
are presented as the mean  standard error of the mean (SEM). For
disease scores, experimental results were analyzed by the Mann-Whitney
test. Statistical analyses were performed using GraphPad Prism software
(version 4.0b; GraphPad Software Inc.). Differences in means were con-
sidered significant at a P value of0.05.
RESULTS
Subcellular localizationof the 6kproteins inRRV-infected cells.
We first characterized the distribution and localization of the RRV
6k proteins in RRV-infected BHK-21 cells at 12 h postinfection
(p.i.) by immunofluorescence. When infected cells were processed
by fixation, permeabilization, and immunostaining for either the
RRV 6k proteins or RRV E2, we readily detected these proteins
(Fig. 1A, right), while nonpermeabilized infected cells were posi-
tive for E2 but not the 6k proteins (Fig. 1A, left). This suggests that
the RRV 6k proteins were not exposed to the extracellular space.
When examined with a higher magnification, both the 6k proteins
and E2 were predominantly present at the periphery of the nuclei
with punctate appearances (Fig. 1B), reminiscent of localization
to the vesicular organelles.
We then performed higher-resolution confocal microscopy to
determine the subcellular localization of the 6k proteins (Fig. 2). A
punctate intracellular distribution of the 6k proteins without dis-
cernible accumulation at the plasma membrane was observed.
These intracellular foci did not represent replication complexes, as
evidenced by costaining for the replication intermediate double-
stranded RNA (Fig. 2A). The lack of 6k signals in cells infected
with RRV-(6K) demonstrates the specificity of the staining (Fig.
2B). Further, colocalization analysis with organelle markers
showed that the 6k protein foci in cells infected with WT RRV
extensively colocalized with calnexin, a marker for the ER (Fig.
2C), while the 6k proteins did not colocalize to any considerable
extent with markers for the cis-Golgi network (Fig. 2D), early en-
dosomes (Fig. 2E), or lysosomes (Fig. 2F). Also, the 6k proteins
were not targeted to autophagosomes (Fig. 2G), which accumu-
late in alphavirus-infected cells (25). Thus, this in-depth micro-
scopic analysis shows that the 6k proteins were predominantly
localized to the ER in RRV-infected cells.
Effect of the 6k deletion on RRV temperature and pH sensi-
tivity.We then went on to assess whether the 6k proteins affect the
sensitivity of RRV virions to variations in temperature or pH, as
such a role has been suggested in the context of other alphavirus 6k
mutations (26). To assess the thermostability of virions, WT RRV
and RRV-(6K) particles were treated at elevated temperatures
(52 or 56°C) for 0, 6 and 12 min, before being cooled to 4°C and
assayed by plaque assay. WT RRV and RRV-(6K) were both
completely inactivated following incubation at 56°C, and no dif-
ference in the amount of infectious virus after incubation at 52°C
was found (data not shown), indicating that there was no differ-
ence in the thermal stability of RRV-(6K) and WT virus par-
ticles. To examine the temperature sensitivity of RRV-(6K)
during replication, 10-fold dilutions of either WT RRV or
RRV-(6K) were overlaid onto Vero cells and incubated at differ-
ent temperatures. Variations in temperature did not differentially
affect the infectivity of the WT and mutant viruses at 37°C and
39°C, where similar plaque numbers were counted, while no
plaques were detected at 41°C (Fig. 3A and B). The plaque size of
RRV-(6K) was, however, significantly reduced compared to that
of WT RRV at 39°C but not at 37°C (Fig. 3C). Thus, unlike the
stability of virions and their ability to infect cells, a subsequent step
of the RRV replication cycle was clearly affected by the deletion of
the 6k region.
To examine the effect of deletion of the 6k proteins on the pH
sensitivity of virions, WT RRV and RRV-(6K) particles were
incubated at pH 5.5 for various times prior to neutralization and
subsequent plaque assay. WT RRV was stable at pH 5.5 with no
reduction of infectivity (Fig. 3D). In contrast, RRV-(6K) virions
were sensitive to low pH, as their infectivity was significantly re-
duced following incubation at pH 5.5 for 60 s compared to that of
WT RRV. In summary, we observed a tendency for RRV to have a
higher vulnerability to temperature and pH when it lacked the 6k
proteins.
6k deletion does not affect virus particle production but af-
fects the release of virus particles from BHK-21 cells. Next, we
Taylor et al.
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asked whether deletion of the 6k proteins affected RRV replica-
tion. To this end, BHK-21 cells were infected with either WT RRV
or RRV-(6K), and the supernatants were harvested at various
times postinfection and titrated by plaque assay. At early times
postinfection (0 to 16 h), no significant difference in the amount
of infectious cell-associated WT RRV or RRV-(6K) was ob-
served, suggesting that deletion of the 6k gene did not affect the
rate of replication of RRV (Fig. 4A). However, at late times (24
h) postinfection, the amount of cell-associated RRV-(6K) signif-
icantly increased compared to the amount of WT RRV, indicating
that virions of RRV-(6K) were not efficiently released and accu-
mulated within and/or at the surface of infected cells. Addition-
ally, the significant increase in the amount of WT RRV released
from BHK-21 cells compared to the amount of RRV-(6K) re-
leased, which was especially evident at 16 h p.i. and later time
points, also supports the conclusion that the release of RRV-
(6K) was compromised (Fig. 4B). Complementary RT-qPCR
analysis of culture supernatants and lysates containing cell-as-
sociated virus also revealed evidence of the disturbed release of
RRV-(6K); the cell-associated viral genome copy numbers of
RRV-(6K) significantly increased at 24 h p.i. with respect
to the cell-associated viral genome copy numbers of WT RRV
FIG 1 Cellular distribution of the RRV 6k and E2 proteins in WT RRV-infected BHK-21 cells. BHK-21 cell monolayers were infected with WT RRV at an MOI
of 0.1 for 1 h, placed in fresh growth medium, and incubated for 12 h. (A) Cells were either fixed with paraformaldehyde (nonpermeabilized) or permeabilized
and fixed with paraformaldehyde containing 0.1% Triton X-100. The cellular location of the 6k proteins and the E2 protein was visualized using rabbit polyclonal
antibodies raised against the RRV 6K N-terminal region and the RRV E2 protein, respectively, followed by FITC-conjugated secondary antibodies. Cells were
examined using fluorescence (top row) and light (middle row) microscopy, and merged images (bottom row) were generated. Bar 40m. (B) RRV 6k proteins
and the E2 protein exhibit a punctate distribution in BHK-21 cells. BHK-21 cell monolayers were infected with WT RRV, fixed, and permeabilized at 12 h p.i. and
stained as described in the legend to panel A. Bar 20 m.
RRV 6k Proteins in Cell Dissociation and Disease
April 2016 Volume 90 Number 8 jvi.asm.org 4153Journal of Virology
 o
n
 June 15, 2016 by Australian National Univ.
http://jvi.asm.org/
D
ow
nloaded from
 
(Fig. 4C), a finding which correlates with the larger amount of
infectious cell-associated RRV-(6K) detected (Fig. 4A). The ge-
nome copy numbers of RRV-(6K) were significantly reduced in
culture supernatants at 16 h p.i. though not at 24 h p.i. (Fig. 4D).
This may result from increased survival of RRV-(6K)-infected
cells, allowing a prolonged or more efficient synthesis of viral
RNA. To rule out the possibility that this effect may be caused by
a reduced genome copy number/PFU ratio of RRV-(6K), such
ratios were determined for both WT RRV and RRV-(6K) (data
not shown). No difference was found, indicating that the high
FIG 2 Subcellular localization of the RRV 6k proteins. (A and B) BHK-21 cell monolayers were infected with WT RRV (A) or RRV-(6K) (B) at an MOI of 0.1
for 1 h, placed in fresh growth medium, and incubated for 12 h. Cells were permeabilized and fixed with paraformaldehyde containing 0.1% Triton X-100. The
subcellular localization of the 6k proteins was visualized using rabbit polyclonal antibodies raised against the RRV 6K N-terminal region (pseudocolored red),
combined with staining of the indicated organelles (green). dsRNA, double-stranded RNA. Bar  10 m. (C to G) HOS cells were infected with WT RRV as
indicated and fixed and permeabilized, followed by costaining for the 6kproteins (red) and the indicated organelle marker (green). Mouse monoclonal antibodies
against calnexin, GM130, EEA1, and LAMP1 were used to stain the ER (C), cis-Golgi network (D), early endosomes (E), and lysosomes (F), respectively. (G)
Autophagosomes were detected by fluorescence of EGFP-tagged LC3 in HOS cells stably transfected with this marker.
Taylor et al.
4154 jvi.asm.org April 2016 Volume 90 Number 8Journal of Virology
 o
n
 June 15, 2016 by Australian National Univ.
http://jvi.asm.org/
D
ow
nloaded from
 
genome copy number of RRV-(6K) in the cell culture superna-
tant at 24 h p.i. may be due to the release of virus RNA-containing
cell debris into the culture medium. Together these data suggest
that, although virus production was not reduced, deletion of 6k
inhibited the release of RRV from host cells.
RRV-(6K)-infectedmice showa reduced severity anddura-
tion of RRV disease. Several in vivo studies examining the role of
the alphavirus structural proteins have outlined the importance of
the envelope glycoproteins in viral pathogenesis (27, 28). How-
ever, little is known about the effect of the 6k proteins on alphavi-
ral virulence. To examine this for RRV, Swiss mice were mock
infected or infected with 103 PFU of WT RRV or RRV-(6K) and
monitored for disease signs and body weight. WT RRV-infected
mice developed severe disease signs, including a loss of hind limb
grip strength and dragging of the hind limbs. These disease signs
peaked at day 10 p.i. and resolved by day 20 (Fig. 5A). Further-
more, WT RRV-infected mice failed to gain weight, showing signs
of wastage, which also peaked at day 10 p.i. (Fig. 5B). In contrast,
RRV-(6K)-infected mice did not present the same severity of
disease as WT RRV-infected mice, showing only mild hind limb
weakness and a low level of lethargy. This mild disease peaked at
day 6 and resolved by day 12 p.i. (Fig. 5A). RRV-(6K)-infected
mice also started to gain weight by day 8 (Fig. 5B). In addition, a
significant decrease in the viral load was found in both the quad-
riceps muscle (Fig. 5C) and the ankle joints (Fig. 5D) of RRV-
(6K)-infected mice. While peak viral titers in WT RRV-infected
FIG 3 RRV-(6K) temperature and pH sensitivity. (A) Representative plaque phenotypes of WT RRV and RRV-(6K) at the specified temperatures. (B)
Average plaque count for WT RRV and RRV-(6K) at 37°C and 39°C. The plaque count was zero at 41°C. The data represent the means SEMs from three
independent determinations. (C) Average plaque diameter for WT RRV and RRV-(6K) at 37°C and 39°C. (D) Relative amount of infectious WT RRV and
RRV-(6K) after exposure to pH 5.5 for the indicated times normalized to the amount at time zero (100%). The data represent the means SEMs from three
independent determinations. P values were determined by Student’s unpaired t test. **, P 0.01; ***, P 0.001.
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mice were observed at day 5 p.i., RRV-(6K) titers in the quadri-
ceps muscle peaked at day 3 and were markedly lower than those
of WT RRV. A significant decrease in the RRV-(6K) titer in
comparison to the WT RRV titer was observed in both quadriceps
muscle and ankle joint tissues from day 5 p.i. RRV-(6K) was
cleared from the ankle joints of infected mice at day 8 p.i. In
addition, we detected viral RNA in the ankle joints of mice up to 1
month p.i. with WT RRV but not with RRV-(6K) (Fig. 5E),
indicating the persistence of WT RRV but not the 6k mutant.
RRV-(6K) immunization results in a reduced viral burden
during alphaviral infection. As RRV-(6K) showed significantly
reduced virulence in the host, we tested its prophylactic efficacy.
Mice were immunized with 104 PFU of RRV-(6K) or mock im-
munized with PBS and at day 30 p.i. were challenged with a high
dose (106 PFU) of WT RRV or CHIKV. As shown in Fig. 6, RRV-
(6K)-immunized mice showed an overall reduced viral load in
serum after infection with RRV (Fig. 6A) or CHIKV (Fig. 6B).
Immunization with RRV-(6K) resulted in the effective reduc-
tion of the RRV load already by day 1 p.i. (Fig. 6A). When the
RRV-(6K)-immunized mice were challenged with CHIKV, viral
titers at day 2 were reduced 10-fold compared to those in mock-
immunized mice (Fig. 6B), indicating cross protection. By day 3
postchallenge, infectious virus was cleared from the serum of
RRV-(6K)-immunized mice but not control mice in both RRV-
and CHIKV-challenged mice (Fig. 6). These findings suggest that
RRV-(6K) immunization offers protection against reinfection
with the same or even a closely related alphavirus by reducing the
viral burden in the host.
DISCUSSION
Little is known about the importance and role of the RRV 6k
proteins, 6K and TF, during virus infection and replication. A
number of previous studies have used partial gene deletions or
insertions to investigate the role of the alphaviral 6K protein (8, 9).
However, in such mutants, it is not known whether protein func-
tion is completely abolished. Also, it is not known whether these
approaches result in the expression of a novel protein with differ-
ent properties and what effects that this might have on processes
such as viral replication and host cell metabolism (29, 30). Fur-
thermore, the recent discovery of TF, the result of a translational
frameshift in the 6k gene, brings added uncertainty to the validity
of these approaches (2, 31). Additionally, the 6k gene is not highly
conserved between alphaviruses, making it difficult to compare
findings in different alphaviruses. In this study, an RRV mutant
containing an in-frame deletion of the entire 6k gene region was
constructed, thereby ensuring that the translation of proteins en-
coded by sequences on either side of the 6k gene region remained
unaffected. This mutant is directly analogous to the alphavirus 6k
deletion mutant of SFV described previously (11).
Immunofluorescence detection of the 6k proteins showed a
punctate perinuclear distribution, suggesting that these proteins
were largely retained within the cell. The 6k proteins were not
detectable in RRV-infected nonpermeabilized cells by immuno-
fluorescence, indicating that the epitope for the 6k antibody, the
N-terminal end of the 6k proteins, was not detectably exposed at
the cell surface in infected cells. The predominant localization of
the RRV 6k proteins was at the ER, in line with the findings of
FIG 4 Deletion of RRV 6k has no effect on RRV particle production in BHK-21 cells but inhibits particle release. BHK-21 cells were infected with either WT RRV
or RRV-(6K) at an MOI of 0.1 for 1 h and placed in growth medium. (A and B) Quantification of infectious cell-associated virus (A) and virus released into the
cell culture supernatant (B) by plaque assay. The limit of detection for the plaque assay was 10 PFU/ml. (C and D) Determination of viral genome copy numbers
by RT-qPCR at the indicated times p.i. for cell-associated virus (C) and virus in the culture supernatant (D). P values were determined by Student’s unpaired t
test. *, P 0.05; **, P 0.01; ***, P 0.001.
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previous studies on SINV (4) and SFV (7) 6k proteins. At the ER,
the alphaviral 6k proteins may function as ion channels, thereby
disrupting calcium homeostasis by the sustained release of cal-
cium from the ER store (13, 31). The sustained release of calcium
from the ER store leads to increased cytoplasmic calcium levels,
triggering cell shrinkage and cell permeabilization, which are
likely to play a role in the later stages of alphavirus replication,
such as viral budding and release (15). The subcellular localization
of the 6k proteins was, however, not completely congruent with
the ER, implying some shuttling of 6K/TF to other vesicular or-
ganelles and/or the plasma membrane.
The reduced infectious RRV-(6K) titers for released but not
cell-associated virus suggest that the RRV 6k proteins are required
for efficient viral dissociation from the cell. The inefficient cell
dissociation of RRV-(6K) virions may be linked to the formation
of ion channels by the 6k proteins (16). Membrane permeabiliza-
tion by ion channel formation leads to changes in the local mem-
brane potential, creating an environment thought to promote al-
phaviral budding (9, 32). This defect in cell dissociation was most
likely enhanced at 39°C, as at this temperature RRV-(6K) made
the same number of plaques as WT RRV, but the plaques were
smaller than those of WT RRV. With the 6K protein of SFV
thought to play a role in the organization and stability of the het-
erodimeric E1-E2 glycoprotein complex, it is possible that dele-
tion of the RRV 6k proteins may influence the downstream pro-
cessing and/or trafficking of the RRV glycoproteins and ultimately
affect virus assembly and replication (31, 33). Notably, in contrast
to RRV-(6K), the SFV 6k deletion mutant demonstrated a dra-
matic decrease in the rate of viral replication (5, 11). In addition, a
6k deletion mutant of salmonid alphavirus (SAV) was found to be
nonviable (34), outlining the functional divergence of the 6k pro-
teins in different alphaviruses.
FIG 5 RRV-induced disease in mice infected with WT RRV and RRV-(6K). Seventeen-day-old outbred Swiss mice were infected with 103 PFU of WT RRV or
RRV-(6K) by intraperitoneal injection. Mock-inoculated mice were injected with PBS alone. (A) Mice were scored for lethargy and hind limb dysfunction on
the basis of the following scale: 0, no disease signs; 1, ruffled fur; 2, very mild hind limb weakness; 3, mild hind limb weakness; 4, moderate hind limb weakness
and dragging of hind limbs; 5, severe dragging; 6, complete loss of hind limb function; 7, moribund state. Data for disease scores were analyzed by the
Mann-Whitney test. *, P 0.05; **, P 0.01. (B) Mice were monitored daily for changes in weight. Values are the means SEMs for 8 mice per group. *, P
0.05. (C and D) On days 1, 3, 5, and 8 p.i., the quadriceps muscle (C) and ankle joints (D) were collected and the amount of infectious virus was determined by
plaque assay. The limit of detection for the plaque assay was 10 PFU/ml. The data represent the means SEMs for 4 mice per group and are representative of those
from two separate experiments. P values were determined by Student’s unpaired t test.*, P 0.05; **, P 0.01; ***, P 0.001. (E) RT-PCR analysis of the E2
region of viral RNA in the ankle joint tissue of WT RRV- or RRV-(6K)-infected mice at different times after infection. The hypoxanthine-guanine phospho-
ribosyltransferase (HPRT) housekeeping gene was used as a loading control. Lanes 1, day 5 p.i.; lanes 2, day 10 p.i.; lanes 3, day 15 p.i.; lanes 4, day 30 p.i.
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In animal studies, RRV-(6K)-infected mice did not show dis-
ease of the same severity as that in WT RRV-infected mice. RRV-
(6K) induced mild disease, which culminated and resolved 4 and
8 days earlier, respectively, than WT RRV disease. RRV-(6K)-
infected mice continued to gain weight, in contrast to WT RRV-
infected mice. These observations are in line with those of previ-
ous studies into the role of SINV TF during infection in vivo,
which found that mice infected with an SINV TF deletion mutant
developed a disease less severe than that in mice infected with WT
SINV (6). The attenuated disease in mice infected with the SINV
TF deletion mutant was associated with a reduced viral burden in
the target organs (6), much like the reduced viral titers observed
here in the quadriceps muscle and ankle joint of RRV-(6K)-
infected mice. It is therefore likely that the inefficient release of
RRV-(6K) from the host cell, observed in vitro, contributed to
the reduced viral burden in RRV-(6K)-infected mice and, sub-
sequently, the reduced inflammation and disease. In this regard,
no RRV RNA was detectable within joint tissue of RRV-(6K)-
infected mice at 30 days postinfection.
The attenuated nature of infection with RRV-(6K) provides
the possibility for using this virus as a vaccine vector, avoiding
severe RRV disease. Similarly, Hallengärd and colleagues reported
that CHIKV with a 6kdeletion was also attenuated in vivo, induced
high levels of neutralizing antibodies, and protected animals
against viremia and joint swelling upon challenge with WT
CHIKV (35). Thus, the deletion of 6khas the potential to generally
attenuate alphaviruses and may be used as a potential vaccination
strategy against RRV. Importantly, our results show that immu-
nization with RRV-(6K) also protected against disease upon
challenge with the related arthritogenic alphavirus CHIKV. This is
evidence for cross protection, a phenomenon reported for the
respective wild-type viruses and may be caused by the induction of
broadly neutralizing antialphavirus antibodies (36, 37). Thus,
vaccination with a 6k deletion virus has the potential to protect
against disease by several related alphaviruses.
In conclusion, we describe the phenotypic properties of an
RRV 6k deletion mutant, whereby the 6k gene locus likely plays a
key role in the enhanced pathogenicity exhibited by RRV. Under-
standing the viral genetic loci that govern pathogenesis could ul-
timately lead to the development of safer and more immunogenic
alphavirus vectors for vaccine delivery. In this regard, manipulat-
ing the 6k gene locus could be a potential strategy for future viral
vector-based vaccine development.
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